EVIDENCE OF PHENOTYPIC ALTERATION AS A CAUSE OF SYSTOLIC DYSFUNCTION IN THE FAILING HEART

Agerholm-Larsen, 1997, ACE gene polymorphism: Ischemic heart disease and longevity in 10,150 individuals: A case-referent and retrospective cohort study based on the Copenhagen City Heart Study, Circulation, 95, 2358, 10.1161/01.CIR.95.10.2358 Anderson, 1997, Autonomic nervous system activity before PVC-triggered and nonPVC-triggered spontaneous sustained ventricular tachycardia [abstr], Circulation, 96, 124 Bachmaier, 1997, Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease, Circulation, 95, 655, 10.1161/01.CIR.95.3.655 Balligand, 1994, Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro, J Biol Chem, 269, 27580, 10.1016/S0021-9258(18)47024-X Benovic, 1987, Purification and characterization of the β-adrenergic receptor kinase, J Biol Chem, 262, 9026, 10.1016/S0021-9258(18)48041-6 Benovic, 1986, β-adrenergic receptor kinase: Identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor, Proc Natl Acad Sci U S A, 83, 2797, 10.1073/pnas.83.9.2797 Bolling, 1992, Prolongation of cardiac allograft survival in rats by anti-TNF and cyclosporine combination therapy, Transplantation, 53, 283, 10.1097/00007890-199202010-00006 Brillantes, 1992, Differences in cardiac calcium release channel (rhyanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy, Circ Res, 71, 18, 10.1161/01.RES.71.1.18 Bristow, 1982, Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts, N Engl J Med, 307, 205, 10.1056/NEJM198207223070401 Bristow, 1986, Beta 1 and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: Coupling of both receptor subtypes to muscle contraction and selective beta 1 receptor down-regulation in heart failure, Circ Res, 59, 297, 10.1161/01.RES.59.3.297 Bristow, 1990, β-adrenergic pathways in nonfailing and failing human ventricular myocardium, Circulation, 82, I-12 Bristow, 1993, Decreased β1-adrenergic receptor mRNA levels in the failing human heart, J Clin Invest, 92, 2737, 10.1172/JCI116891 Carswell, 1975, An endotoxin-induced serum factor that causes necrosis of tumors, Proc Natl Acad Sci U S A, 72, 3666, 10.1073/pnas.72.9.3666 Cheng, 1996, Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure, Circ Res, 78, 880, 10.1161/01.RES.78.5.880 Chung, 1990, Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: Impairment of signal transduction, Circ Res, 67, 753, 10.1161/01.RES.67.3.753 Cohn, 1984, Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure, N Engl J Med, 311, 819, 10.1056/NEJM198409273111303 1987, Effects of enalapril on mortality in severe congestive heart failure, N Engl J Med, 316, 1429, 10.1056/NEJM198706043162301 Corral, 1996, Selection of novel analogs of thalidomide with enhanced tumore necrosis factor α inhibitory activity, Mol Med, 2, 506, 10.1007/BF03401909 Costerousse, 1993, Angiotenins I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes, Biochemistry, 290, 33, 10.1042/bj2900033 D'Agnolo, 1992, Contractile properties and Ca2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy, Circulation, 85, 518, 10.1161/01.CIR.85.2.518 Deng, 1995, The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation, Transplantation, 60, 1118, 10.1097/00007890-199511270-00011 Deswal, 1998, A phase I trial of tumor necrosis factor receptor (p75) fusion protein (TNPR:Fc) in patients with advanced heart failure [abstr], Circulation, 1323 Drucker, 1994, Gammaglobulin treatment of acute myocarditis in the pediatric population, Circulation, 89, 252, 10.1161/01.CIR.89.1.252 Dwyer, 1992, Manipulating the immune system with immune globulin [review], N Engl J Med, 326, 107, 10.1056/NEJM199201093260206 Evans, 1989, Metabolic effects of tumor necrosis factor-α (cachectin) and interleukin-1, Clin Sci, 77, 357, 10.1042/cs0770357 Feldman, 1991, Experimental issues in assessment of G-protein function in cardiac disease, Circulation, 84, 1852, 10.1161/01.CIR.84.4.1852 Feldman, 1989, Altered expression of α-subunits of G-proteins in failing human hearts, J Mol Cell Cardiol, 21, 359, 10.1016/0022-2828(89)90646-9 Feldman, 1988, Increase of the 40,000-mol wt pertussis toxin substrate (G-protein) in the failing human heart, J Clin Invest, 82, 189, 10.1172/JCI113569 Feldman, 1991, Expression of α-subunits of G-proteins in failing human heart: A reappraisal utilizing quantitative polymerase chain reaction, J Mol Cell Cardiol, 23, 1355, 10.1016/0022-2828(91)90182-L Feldman, 1991, Selective gene expression in failing human heart: Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction, Circulation, 83, 1866, 10.1161/01.CIR.83.6.1866 Feldman, 1993, Selective changes in gene programming characterize the transition from hypertrophy to failure in aortic banded rats, Circ Res, 73, 184, 10.1161/01.RES.73.1.184 Finkel, 1992, Negative inotropic effects of cytokines on the heart mediated by nitric oxide, Science, 257, 387, 10.1126/science.1631560 Fowler, 1986, Assessment of the β-adrenergic receptor pathway in the intact failing human heart: Progressive receptor downregulation and subsensitivity to agonist response, Circulation, 74, 1290, 10.1161/01.CIR.74.6.1290 Garvas, 1975, Angiotensin- and norepinephrine-induced myocardial lesions: Experimental and clinical studies in rabbits and man, 89, 332 Gaudin, 1995, Overexpression of Gsα protein in the hearts of transgenic mice, J Clin Invest, 95, 1676, 10.1172/JCI117843 Gilbert, 1993, Lisinopril lowers cardiac adrenergic drive and increases β-receptor density in the failing human heart, Circulation, 88, 472, 10.1161/01.CIR.88.2.472 Ginsburg, 1993, Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenol, Am Heart J, 106, 535, 10.1016/0002-8703(83)90698-1 Giordano, 1997, Adenovirus-mediated gene transfer reconstitutes depressed sarcoplasmic reticulum Ca2+-ATPase levels and shortens prolonged cardiac myocyte Ca2+ transients, Circulation, 96, 400, 10.1161/01.CIR.96.2.400 Gulick, 1989, Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness, Proc Natl Acad Sci U S A, 86, 6753, 10.1073/pnas.86.17.6753 Gwathmey, 1987, Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure, Circ Res, 61, 70, 10.1161/01.RES.61.1.70 Hajjar, 1997, Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes, Circ Res, 81, 145, 10.1161/01.RES.81.2.145 Harel, 1992, A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin: Possible involvement of TNF in hemolytic uremic syndrome, J Clin Invest, 92, 2110, 10.1172/JCI116811 Hasenfuss, 1994, Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium, Circ Res, 75, 434, 10.1161/01.RES.75.3.434 Hasking, 1986, Norepinephrine spillover to plasma in patients with congestive heart failure: Evidence of increased overall and cardiorenal sympathetic nervous activity, Circulation, 73, 615, 10.1161/01.CIR.73.4.615 Hausdorff, 1990, Turning off the signal: Desensitization of β-adrenergic receptor function, FASEB J, 4, 2881, 10.1096/fasebj.4.11.2165947 He, 1997, Overexpression of the rat sarcoplasmic reticulum Ca2+-ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation, J Clin Invest, 100, 380, 10.1172/JCI119544 Hennein, 1994, Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization, J Thorac Cardiovasc Surg, 108, 626, 10.1016/S0022-5223(94)70286-1 Hoit, 1995, In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency, Circ Res, 77, 632, 10.1161/01.RES.77.3.632 Iwase, 1997, Cardiomyopathy induced by cardiac G S alpha overexpression, Am J Physiol, 272, H585 Kapadia, 1997, Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium, Circ Res, 81, 187, 10.1161/01.RES.81.2.187 Kapadia, 1995, Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro, Am J Physiol, 268, H517 Kindler, 1989, The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection, Cell, 56, 731, 10.1016/0092-8674(89)90676-4 Klement, 1996, IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice, Mol Cell Biol, 16, 2341, 10.1128/MCB.16.5.2341 Koch, 1996, Transgenic manipulation of myocardial G-protein-coupled receptors and receptor kinases, Circ Res, 78, 511, 10.1161/01.RES.78.4.511 Koch, 1995, Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a βARK inhibitor, Science, 268, 1350, 10.1126/science.7761854 Kolls, 1994, Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer, Proc Natl Acad Sci U S A, 91, 215, 10.1073/pnas.91.1.215 Konstam, 1992, Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure, Circulation, 86, 431, 10.1161/01.CIR.86.2.431 Kubota, 1998, Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure, Circulation, 97, 2499, 10.1161/01.CIR.97.25.2499 Kubota, 1997, Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice, J Cardiac Failure, 3, 117, 10.1016/S1071-9164(97)90045-2 Kubota, 1997, Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha, Circ Res, 81, 627, 10.1161/01.RES.81.4.627 Kupferminc, 1994, Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia, Am J Obstet Gynecol, 170, 1752, 10.1016/S0002-9378(94)70351-5 Ladenson, 1992, Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism, Proc Natl Acad Sci U S A, 82, 5251, 10.1073/pnas.89.12.5251 Larrick, 1988, The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response, Pharm Res, 5, 129, 10.1023/A:1015904721223 Latini, 1994, Cytokines in acute myocardial infarction: Selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist, J Cardiovasc Pharmacol, 23, 1, 10.1097/00005344-199401000-00001 Levine, 1990, Elevated circulating levels of tumor necrosis factor in severe chronic heart failure, N Engl J Med, 323, 236, 10.1056/NEJM199007263230405 Li, 1998, Interleukin-1β alters the expression of an Eph-related receptor tyrosine kinase gene (r-EphA3) in neonatal rat cardiomyocytes, Am J Physiol, H331 Lin, 1992, Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat, J Heart Lung Transplant, 11, 330 Linck, 1996, Messenger RNA expression and immunological quantification of phospholamban and SR-Ca2+-ATPase in failing and nonfailing human hearts, Cardiovasc Res, 31, 625, 10.1016/S0008-6363(95)00236-7 Lindpaintner, 1996, Absence of associate or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass, N Engl J Med, 334, 1023, 10.1056/NEJM199604183341604 Linz, 1989, Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats, Clin Exp Hypertens, 11, 1325, 10.3109/10641968909038172 Liu, 1997, Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: Role of kinins and angiotensin II type 2 receptors, J Clin Invest, 99, 1926, 10.1172/JCI119360 Lowes, 1997, Downregulation of alpha- and upregulation of β-myosin heavy chain in intact, failing human ventricles [abstr], J Am Coll Cardiol, 29, 423A Luo, 1994, Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation, Circ Res, 75, 401, 10.1161/01.RES.75.3.401 Luo, 1996, Phospholamban gene dosage effects in the mammalian heart, Circ Res, 78, 839, 10.1161/01.RES.78.5.839 MacDonald, 1994, Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage, J Am Coll Cardiol, 24, 1762, 10.1016/0735-1097(94)90185-6 MacGowan, 1997, Circulating interleukin-6 in severe congestive heart failure, Am J Cardiol, 79, 1128, 10.1016/S0002-9149(96)00063-X Magnusson, 1990, Mapping of a functional autoimmune epitope on the β1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy, J Clin Invest, 86, 1658, 10.1172/JCI114888 Manicourt, 1993, Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis: Relationship to serum levels of hyaluronan and antigenic keratan sulfate, Arthritis Rheum, 36, 490, 10.1002/art.1780360409 Matsumori, 1997, Amiodarone inhibits production of tumor necrosis factor-α by human mononuclear cells: A possible mechanism for its effect in heart failure, Circulation, 96, 1386, 10.1161/01.CIR.96.5.1386 Matsumori, 1997, Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain, Circulation, 96, 1501, 10.1161/01.CIR.96.5.1501 Matsumori, 1994, Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure, Circulation, 89, 955, 10.1161/01.CIR.89.3.955 McNamara, 1997, Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy, Circulation, 95, 2476, 10.1161/01.CIR.95.11.2476 McTiernan, 1997, Interleukin-1beta inhibits phospholamban gene expression in cultured cardiomyocytes, Circ Res, 81, 493, 10.1161/01.RES.81.4.493 Mercadier, 1990, Altered sarcoplasmic reticulum Ca2+-ATPase gene expression in the human ventricle during end-stage heart failure, J Clin Invest, 85, 305, 10.1172/JCI114429 Meyer, 1995, Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy, Circulation, 92, 778, 10.1161/01.CIR.92.4.778 Milano, 1994, Enhanced myocardial function in transgenic mice overexpressing the beta sub 2-adrenergic receptor, Science, 264, 582, 10.1126/science.8160017 Miyazaki, 1995, Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis: A mouse model of progressive pulmonary fibrosis, J Clin Invest, 96, 250, 10.1172/JCI118029 Moreland, 1997, Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein, N Engl J Med, 337, 141, 10.1056/NEJM199707173370301 Morgan, 1991, Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction, N Engl J Med, 325, 625, 10.1056/NEJM199108293250906 Morgan, 1990, Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure, Circulation, 81, III-21 Ohkubo, 1990, Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes, Proc Natl Acad Sci U S A, 87, 5153, 10.1073/pnas.87.13.5153 Peppel, 1993, Expression of a TNF inhibitor in transgenic mice, J Immunol, 151, 5699 Pfeffer, 1985, Influence of chronic captopril therapy on the infarcted left ventricle of the rat, Circ Res, 57, 84, 10.1161/01.RES.57.1.84 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 Pieske, 1996, Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy, J Clin Invest, 98, 764, 10.1172/JCI118849 Pouleur, 1993, Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction, Circulation, 88, 481, 10.1161/01.CIR.88.2.481 Probert, 1995, Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha, Proc Natl Acad Sci U S A, 92, 11294, 10.1073/pnas.92.24.11294 Probert, 1995, The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice, Eur J Immunol, 25, 1794, 10.1002/eji.1830250647 Reis, 1993, Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: Presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes, Am J Trop Med Hyg, 48, 637, 10.4269/ajtmh.1993.48.637 Rigat, 1990, An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels, J Clin Invest, 86, 1343, 10.1172/JCI114844 Rockman, 1996, Receptor-specific in vivo desensitization by the G-protein-coupled receptor kinase-5 in transgenic mice, Proc Natl Acad Sci U S A, 93, 9954, 10.1073/pnas.93.18.9954 Rockman, 1996, Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the β2-adrenergic receptor is associated with reduced phospholamban protein, J Clin Invest, 97, 1618, 10.1172/JCI118587 Sabbah, 1994, Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction, Circulation, 89, 2852, 10.1161/01.CIR.89.6.2852 Sadoshima, 1993, Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype, Circ Res, 73, 413, 10.1161/01.RES.73.3.413 Sandborn, 1997, A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease, Gastroenterology, 113, 1042, 10.1016/S0016-5085(97)70205-1 Schocken, 1977, Reduced β-adrenergic receptor concentrations in ageing man, Nature, 267, 856, 10.1038/267856a0 Schulz, 1995, The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha, Br J Pharmacol, 114, 27, 10.1111/j.1476-5381.1995.tb14901.x Schwartz, 1993, Molecular phenotype of the hypertrophied and failing myocardium, Circulation, 87, VII-5 Schwieler, 1992, Influence of angiotensin-converting enzyme inhibition on sympathetic neurotransmission: Possible roles of bradykinin and prostaglandins, J Cardiovasc Pharmacol, 20, S39, 10.1097/00005344-199200209-00009 Schwinger, 1995, Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts, Circulation, 92, 3220, 10.1161/01.CIR.92.11.3220 Shindo, 1995, Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines, Cardiovasc Res, 29, 813, 10.1016/0008-6363(96)88617-2 Shiraishi, 1995, The inhibitor cytokine interleukin-1 receptor antagonist synergistically augments cyclosporine immunosuppression in a rat cardiac allograft model, J Surg Res, 58, 465, 10.1006/jsre.1995.1073 Spinale, 1995, Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy: Effects on left ventricular and myocyte structure and function, Circulation, 92, 562, 10.1161/01.CIR.92.3.562 1992, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions, N Engl J Med, 327, 685, 10.1056/NEJM199209033271003 Strasser, 1985, Homologous desensitization of β-adrenergic receptor coupled adenylate cyclase, J Biol Chem, 260, 4561, 10.1016/S0021-9258(18)89105-0 Studer, 1994, Gene expression of the cardiac Na+-Ca2+ exchanger in end-stage human heart failure, Circ Res, 75, 443, 10.1161/01.RES.75.3.443 Suffredini, 1995, Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration, J Immunol, 155, 5038 Suzuki, 1993, Rat angiotensin II (Type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy, Circ Res, 73, 439, 10.1161/01.RES.73.3.439 Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730 Takahashi, 1992, Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure, J Clin Invest, 90, 927, 10.1172/JCI115969 Tan, 1991, Cardiac myocyte necrosis induced by angiotensin II, Circ Res, 69, 1185, 10.1161/01.RES.69.5.1185 Targan, 1997, for the Crohn's disease cA2 study group: A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease, N Engl J Med, 337, 1035, 10.1056/NEJM199710093371502 Teoh, 1995, Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery, Circulation, 92, II347, 10.1161/01.CIR.92.9.347 Tiret, 1992, Evidence, from combined segregation and linkage analysis, that a variant of the angiotensins I-converting enzyme (ACE) gene controls plasma ACE levels, Am J Hum Genet, 51, 197 Toews, 1984, Relationship between an altered membrane form and a low affinity for the β-adrenergic receptor occurring during catecholamine-induced desensitization, J Biol Chem, 259, 11844, 10.1016/S0021-9258(20)71288-3 Torre-Amione, 1996, Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD), J Am Coll Cardiol, 27, 1201, 10.1016/0735-1097(95)00589-7 Torre-Amione, 1995, Expression and functional significance of tumor necrosis factor receptors in human myocardium, Circulation, 92, 1487, 10.1161/01.CIR.92.6.1487 Torre-Amione, 1996, Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart, Circulation, 93, 704, 10.1161/01.CIR.93.4.704 Turki, 1996, Myocardial signaling defects and impaired cardiac function of a human β2-adrenergic receptor polymorphism expressed in transgenic mice, Proc Natl Acad Sci U S A, 93, 10483, 10.1073/pnas.93.19.10483 Ungerer, 1993, Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart, Circulation, 87, 454, 10.1161/01.CIR.87.2.454 Ungerer, 1994, Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart, Circ Res, 74, 206, 10.1161/01.RES.74.2.206 Ungureanu-Longrois, 1995, Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to beta-adrenergic agonists, Circ Res, 77, 494, 10.1161/01.RES.77.3.494 Vaddi, 1994, Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease: Relevance in superoxide anion generation [see comments], Circulation, 90, 694, 10.1161/01.CIR.90.2.694 Vilcek, 1991, Tumor necrosis factor, J Biol Chem, 266, 7313, 10.1016/S0021-9258(20)89445-9 Wagner, 1998, Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-α, Circ Res, 82, 47, 10.1161/01.RES.82.1.47 Wagner, 1998, Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-α in the failing human heart, Circulation, 97, 521, 10.1161/01.CIR.97.6.521 Wan, 1996, Human cytokine responses to cardiac transplantation and coronary artery bypass grafting, J Thorac Cardiovasc Surg, 111, 469, 10.1016/S0022-5223(96)70458-0 Weber, 1992, Remodeling and reparation of the cardiovascular system, J Am Coll Cardiol, 20, 3, 10.1016/0735-1097(92)90130-F Weinberg, 1994, Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis, Circulation, 90, 1410, 10.1161/01.CIR.90.3.1410 White, 1994, Age-related changes in β-adrenergic neuroeffector systems in the human heart, Circulation, 90, 1225, 10.1161/01.CIR.90.3.1225 Williams, 1994, Endomyocardial gene expression during development of pacing tachycardia induced heart failure in the dog, Circ Res, 615, 10.1161/01.RES.75.4.615 Wu, 1992, Cytokine gene expression in rejecting cardiac allografts, Transplantation, 54, 326, 10.1097/00007890-199208000-00024 Yokoyama, 1993, Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart, J Clin Invest, 92, 2303, 10.1172/JCI116834